Lateral Flow Microarray Rapid Tests

About QuantiScientifics

QuantiScientifics is a privately-held, US-based biotech firm founded in 2015 that operates at the intersection of diagnostics and AI/machine learning. The company has developed a proprietary multiplex assay platform (A2 technology) that simplifies and accelerates the creation of custom immunoassays for research and diagnostic use. It generates revenue through the sale of assay plates, kits, and contract research/consulting services, primarily targeting the food allergy and sensitivity testing markets. Leadership is anchored by its founder, an experienced inventor in microarray technology, indicating a deep technical foundation.

Therapeutic Areas